JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
VanEck International High Yield Bond ETF
IHY
$41.5M
| $1.02M | ﹤0.01% |
39,902
+606
| +2% | +$15.5K |
2017 Q1
3 quarters
|
|
|
BMCH
3552
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.02M | ﹤0.01% |
+40,383
| New | +$905K |
2017 Q4
0 quarters
|
|
3553
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
| $1.02M | ﹤0.01% |
+15,005
| New | +$1.01M |
2017 Q4
0 quarters
|
|
|
FNSR
3554
CALL
DELISTED
Finisar Corp
FNSR
| $1.02M | ﹤0.01% |
50,000
| – | – |
2017 Q3
1 quarter
|
|
3555
iShares US & Intl High Yield Corp Bond ETF
GHYG
$190M
| $1.02M | ﹤0.01% |
20,135
+1,834
| +10% | +$93.4K |
2016 Q4
4 quarters
|
|
|
GBL
3556
DELISTED
GAMCO Investors, Inc.
GBL
| $1.02M | ﹤0.01% |
34,255
+33,181
| +3,089% | +$970K |
2016 Q4
4 quarters
|
|
|
HTBK
3557
DELISTED
Heritage Commerce
HTBK
| $1.01M | ﹤0.01% |
66,212
+4,912
| +8% | +$74.7K |
2016 Q4
4 quarters
|
|
3558
PUT
Elevance Health
ELV
$82.8B
| $1.01M | ﹤0.01% |
4,500
| – | – |
2017 Q3
1 quarter
|
|
|
AYR
3559
DELISTED
Aircastle Ltd
AYR
| $1.01M | ﹤0.01% |
43,252
+23,876
| +123% | +$561K |
2015 Q4
8 quarters
|
|
3560
CALL
AMC Global Media
AMCX
$463M
| $1.01M | ﹤0.01% |
+18,700
| New | +$998K |
2017 Q4
0 quarters
|
|
3561
Gran Tierra Energy
GTE
$354M
| $1.01M | ﹤0.01% |
37,450
-1,805
| -5% | -$40.3K |
2017 Q2
2 quarters
|
|
|
VGR
3562
DELISTED
Vector Group Ltd.
VGR
| $1.01M | ﹤0.01% |
70,233
+51,038
| +266% | +$710K |
2015 Q4
8 quarters
|
|
3563
Altisource Portfolio Solutions
ASPS
$70.5M
| $1.01M | ﹤0.01% |
4,509
-656
| -13% | -$140K |
2017 Q3
1 quarter
|
|
|
PLYA
3564
DELISTED
Playa Hotels & Resorts
PLYA
| $1.01M | ﹤0.01% |
93,356
+19,363
| +26% | +$206K |
2017 Q3
1 quarter
|
|
3565
Federal Agricultural Mortgage
AGM
$2.27B
| $1M | ﹤0.01% |
12,847
-45,973
| -78% | -$3.41M |
2016 Q1
7 quarters
|
|
3566
Ultragenyx Pharmaceutical
RARE
$1.45B
| $1M | ﹤0.01% |
21,667
-169,537
| -89% | -$8.31M |
2014 Q1
15 quarters
|
|
3567
Evogene
EVGN
$6.88M
| $1M | ﹤0.01% |
32,657
+7,504
| +30% | +$295K |
2016 Q1
7 quarters
|
|
3568
CALL
Invitation Homes
INVH
$15.6B
| $1M | ﹤0.01% |
+42,500
| New | +$984K |
2017 Q4
0 quarters
|
|
3569
CALL
PTC Therapeutics
PTCT
$5.35B
| $1M | ﹤0.01% |
+60,000
| New | +$1.02M |
2017 Q4
0 quarters
|
|
3570
Team
TISI
$130M
| $998K | ﹤0.01% |
6,700
-33,624
| -83% | -$4.48M |
2013 Q2
18 quarters
|
|
3571
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.76B
| $997K | ﹤0.01% |
27,834
-800
| -3% | -$27.8K |
2017 Q2
2 quarters
|
|
3572
CALL
Sony
SONY
$137B
| $993K | ﹤0.01% |
110,500
| – | – |
2017 Q1
3 quarters
|
|
|
PAY
3573
PUT
DELISTED
Verifone Systems Inc
PAY
| $985K | ﹤0.01% |
+55,600
| New | +$1.03M |
2017 Q4
0 quarters
|
|
3574
WesBanco
WSBC
$3.61B
| $983K | ﹤0.01% |
24,163
+11,015
| +84% | +$450K |
2013 Q2
18 quarters
|
|
|
ONC
3575
BeOne Medicines Ltd
ONC
$40.6B
| $983K | ﹤0.01% |
+10,058
| New | +$921K |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.